4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,244 | -74.0% | 1,119 | -63.1% | 0.00% | -100.0% |
| Q2 2023 | $54,788 | +37947.2% | 3,032 | -63.8% | 0.00% | -60.0% |
| Q1 2023 | $144 | +73.5% | 8,366 | +124.4% | 0.01% | +66.7% |
| Q4 2022 | $83 | -99.8% | 3,728 | -15.3% | 0.00% | +200.0% |
| Q3 2022 | $35,000 | -27.1% | 4,401 | -36.2% | 0.00% | 0.0% |
| Q2 2022 | $48,000 | +77.8% | 6,903 | +287.4% | 0.00% | – |
| Q1 2022 | $27,000 | -66.7% | 1,782 | -52.0% | 0.00% | -100.0% |
| Q4 2021 | $81,000 | -3.6% | 3,709 | +19.7% | 0.00% | -50.0% |
| Q3 2021 | $84,000 | +265.2% | 3,099 | +219.5% | 0.00% | +100.0% |
| Q2 2021 | $23,000 | -11.5% | 970 | +60.6% | 0.00% | – |
| Q1 2021 | $26,000 | – | 604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 377,777 | $15,659,000 | 5.43% |
| BVF INC/IL | 1,106,070 | $45,847,000 | 1.80% |
| Eagle Health Investments LP | 50,000 | $2,073,000 | 1.33% |
| Ally Bridge Group (NY) LLC | 150,000 | $6,218,000 | 1.07% |
| Casdin Capital, LLC | 780,555 | $32,354,000 | 0.96% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $163,227,000 | 0.45% |
| Pinz Capital Management, LP | 19,900 | $825,000 | 0.38% |
| ArrowMark Colorado Holdings LLC | 1,063,744 | $44,092,000 | 0.34% |
| Perceptive Advisors | 600,256 | $24,881,000 | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $829,000 | 0.23% |